TOULOUSE, France–(BUSINESS WIRE)–Regulatory News: VEXIM (FR0011072602 ‐ ALVXM / PEA-PME) (Paris:ALVXM), a medical device company specializing in the minimally invasive treatment of vertebral fractures, today announced its consolidated sales results for the first quarter 2016. Strong growth in the 1st quarter 2016 (Q1) (€ in thousands) Q1 (as of March 31st) Q1 2016 Q1 2015 Change (%) […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone